Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 11, 2007

Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)

Iwona Wybranska, Malgorzata Malczewska-Malec, Lukasz Partyka, Beata Kiec-Wilk, Katarzyna Kosno, Iwona Leszczynska-Golabek, Anna Zdzienicka, Anna Gruca, Malgorzata Kwasniak and Aldona Dembinska-Kiec
From the journal

Abstract

Background: New tools to identify genotype-phenotype interactions need to be described and implemented. The aim of this study was to identify correlation between the risk originating from gene variation and diet-dependent development of insulin resistance.

Methods: Insulin output in terms of area under the curve after an oral glucose tolerance test (AUC Ins OGTT) and lipid tolerance tests (AUC Ins OLTT) were measured in 167 overweight/obese patients. Estimation of the 18 common gene polymorphisms for obesity risk and standard phenotyping were performed.

Results: Insulin output (AUC Ins OGTT) correlated strongly between both insulin treatments across the whole group. However, within the genotype sub-groups, correlation was lower or did not exist. Using a nutrient-induced insulin output ratio (NIOR), calculated as AUC Ins OLTT/AUC Ins OGTT, values ranged from 0.42 to 5.83 and correlated significantly with body mass index (BMI) and leptin, but not with age, gender, waist-to-hip ratio (WHR) and homeostasis model assessment of insulin resistance (HOMA-IR) or plasma adiponectin. High NIOR was found in a subgroup of carriers of rare allelic variants of genes characteristic for poorer tolerance to lipids in the diet. Low NIOR values were found within a sub-group with rare genetic variants regulating carbohydrate metabolism. Thus, the new insulin index NIOR may distinguish gene variant carriers into groups of glucose- or lipid-sensitive phenotypes.

Conclusions: We suggest that the OLTT/OGTT insulin output ratio (NIOR) may be predictive for identifying individuals who are phenotypically susceptible to insulin resistance in response to high fat or carbohydrate in their habitual diet.

Clin Chem Lab Med 2007;45:1124–32.


Corresponding author: Dr. Iwona Wybranska, Department of Clinical Biochemistry, The Jagiellonian University, Medical College, Kopernika 15a, 31-501 Krakow, Poland Phone: +48-1-24248799, Fax: +48-1-24214073,

Received: 2006-9-18
Accepted: 2007-1-15
Published Online: 2007-09-11
Published in Print: 2007-09-01

©2007 by Walter de Gruyter Berlin New York